Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy | MicrobiomeTrials← Back to trialsNCT07220785
Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-03-13Est. Completion: 2028-05-19
Enrollment target: 28 participants Locations- University of Michigan, Ann Arbor, Michigan, United States
- UT Southwestern Medical Center, Dallas, Texas, United States
- Walter Cantidio University Hospital, Federal University of Ceara - Ebserh, Fortaleza, Ceará, Brazil
- Centro de Pesquisas Clinicas de Natal (Cepclin), Natal, Rio Grande do Norte, Brazil
- Hospital Das Clinicas - School of Medicine Ribeirao Preto, University of Sao Paulo, Ribeirão Preto, São Paulo, Brazil
- Hopital Universitaire Robert-Debre, Paris, France
- Assistance Publique-Hopitaux de Paris (AP-HP), Paris, France
Other microbiome trials you might be interested in
Lipodystrophy Congenital GeneralizedLipodystrophy, Familial PartialTurner Syndrome
Turner syndrome (TS) and congenital lipodystrophy syndromes (LS) are rare conditions with major consequences on cardiome…
Paris, FranceEst. completion Aug 1, 2027
Plasma Cell Myeloma Recurrent
This will be randomized, multicenter, Phase 3, open-label study evaluating subcutaneous (SC) vs intravenous (IV) adminis…
Aurora, United StatesEst. completion Nov 6, 2024